Intestinal adaptation in short bowel syndrome

Journal of Investigative Medicine

Volumn 53, Issue 8, 2005, Pages 402-413

  Cisler, Jason J ^a   Buchman, Alan L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Epidermal growth factor; Gastrin; Glucagon like peptide; Growth factors; Growth hormone; Hepatocyte growth factor; Neurotensin; Short bowel syndrome; Trefoil peptides

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; GASTRIN; GLUCAGON LIKE PEPTIDE 2; GROWTH FACTOR; GROWTH HORMONE; HORMONE; INTERLEUKIN 1; KERATINOCYTE GROWTH FACTOR; NEUROTENSIN; PEPTIDE YY; SCATTER FACTOR; SECRETIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA;

ANATOMY; GASTROINTESTINAL SECRETION; HUMAN; HYDRATION; INTESTINE ADAPTATION; INTESTINE FUNCTION; INTESTINE SURGERY; JEJUNOSTOMY; MORPHOLOGY; NONHUMAN; NUTRIENT; NUTRITION; PARENTERAL NUTRITION; REVIEW; SHORT BOWEL SYNDROME; TREATMENT INDICATION;

ANIMALIA; LOTUS;

EID: 29844438493     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2005.53804     Document Type: Review

References (143)

1. Buchman A, Scopalio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003;124:1111-34.
2. Summers R, Kent T, Osborne J. Effects of drugs, ileal obstruction, and irradiation on rat gastrointestinal propulsion. Gastroenterology 1970;59:731-9.
3. Fich A, Steadman C, Phillips S, et al. Ileocolonic transit does not change after right hemicolectomy. Gastroenterology 1992;103:794-9.
4. Phillips S, Quigley E, Kumar D, et al. Motility of the ileocolonic junction. Gut 1988;29:390-406.
5. Nordgaard I, Hansen B, Mortensen P. Colon as a digestive organ in patients with short bowel. Lancet 1994;343:373-6.
6. Stassoff B. Experimentelle Untersuchungen uber die Kompensatorishchen Vorgange bei Darmresektionen. Beitr Klin Chir 1914;89:527-86.
7. Treem W. Short bowel syndrome. In: Wyllie R, Hyams J, editors. Pediatric gastrointestinal disease. Philadelphia: Saunders: 1993. p. 573-603.
8. Helmrath MA, Erwin CR, Shin CE, et al. Enterocyte apoptosis is increased following small bowel resection. J Gastrointest Surg 1998;2:44-9.
9. Juno R, Knott A, Profitt, S, et al. Preventing enterocyte apoptosis after massive small bowel resection does not enhance adaptation of the intestinal mucosa. J Pediatr Surg 2004;39:907-11.
10. Stern L, Huang F, Kemp C, et al. Bax is required for increased enterocyte apoptosis after massive small bowel resection. Surgery 2000;128:165-70.
11. Tang Y, Swartz-Basile DA, Swietlicki EA, et al. Bax is required for resection-induced changes in apoptosis, proliferation, and members of the extrinsic cell death pathways. Gastroenterology 2004;126:220-30.
12. Nygaard K. Resection of the small intestine in rats. III. Morphological changes in the intestinal tract. Acta Chir Scand 1967;133:233-48.
13. Dowling R, Booth C. Structural and functional changes following small intestinal resection in the rat. Clin Sci 1967;32:139-49.
14. Porus R. Epithelial hyperplasia following massive small bowel resection in man. Gastroenterology 1965;48:753-9.
15. Weinstein L, Shoemaker C, Hersh T, et al. Enhanced intestinal absorption after small bowel resection in man. Arch Surg 1969;99:560-2.
16. De Francesco A, Malfi G, Delsedime L, et al. Histological findings regarding jejunal mucosal in short bowel syndrome. Transplant Proc 1994;26:1455-6.
17. O'Keefe S, Shorter R, Bennet W, et al. Villous hyperplasia is uncommon in patients with massive intestinal resection. Gastroenterology 1992;102:A231.
18. Williamson R. Intestinal adaptation: structural, functional, and cytokinetic changes. N Engl J Med 1978;298:1393-402.
19. Dowling R. Small bowel adaptation and its regulation. Scand J Gastroenterol 1982;74:53-74.
20. Nightingale J, Lennard-Jones J, Gertner D, et al. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gallstones in patients with a short bowel. Gut 1992;33:1493-7.
21. Vanderhoof J, Langnas A. Short-bowel syndrome in children and adults. Gastroenterology 1997;113:1767-78.
22. Messing B, Crenn P, Beau P, et al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 1999;117:1043-50.
23. Levy E, Frileux P, Sandrucci S, et al. Continuous enteral nutrition during the early adaptive stage of the short bowel syndrome. Br J Surg 1988;75:549-53.
24. O'Brien DP, Nelson LA, Huang FS, Warner BW. Intestinal adaptation: structure, function, and regulation. Semin Pediatr Surg 2001;10:56-64.
25. Fukunaga T, Sasaki M, Araki Y, et al. Effects of the soluble fibre pectin on intestinal proliferation, fecal short chain fatty acid production and microbial population. Digestion 2003;67:42-9.
26. Roth J, Frankel W, Zhang W, et al. Pectin improves colonic function in rat short bowel syndrome. J Surg Res 1995;58:240-6.
27. Koruda MJ, Rolandelli RH, Settle RG, et al. The effect of a pectin supplemented elemental diet in intestinal adaptation to massive small bowel resection. JPEN J Parenter Enteral Nutr 1986;10:343.
28. Royall D, Wolever TM, Jeejeebhoy KN. Evidence for colonic conservation of malabsorbed carbohydrates in short bowel syndrome. Am J Gastroenterol 1992;87:751-6.
29. Rombeau JL, Kripke SA. Metabolic and intestinal effects of short-chain fatty acids. JPEN J Parenter Enteral Nutr 1990;14:181S-5S.
30. Tappenden KA, Thomson AB, Wild GB, et al. Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats. Gastroenterology 1997;112:792-802.
31. Tappenden KA, Thomson AB, Wild GE, et al. Short-chain fatty acids increase proglucagon and ornithine decarboxylase messenger RNAs after intestinal resection in rats. JPEN J Parenter Enteral Nutr 1996;20:357-62.
32. Bamba T, Vaja S, Murphy GM, et al. Role of polyamines in the early adaptive response to jejunectomy in the rat: effect of DFMO on the ileal villus:crypt axis. Digestion 1990;46 Suppl 2:410-23.
33. Rokkas T, Vaja S, Murphy GM, et al. Aminoguanidine blocks intestinal diamine oxidase (DAO) activity and enhances the intestinal adaptive response to resection in the rat. Digestion 1990;46 Suppl 2:447-57.
34. Seidel E, Haddox M, Johnson L. Ileal mucosal growth during intraluminal infusion of ethylamine or putrescine. Am J Physiol 1985;249:G434-8.
35. Wakabayashi Y, Yamada E, Yoshida T, et al. Effect of intestinal resection and arginine-free diet on rat physiology. Am J Physiol 1995;32:G313-8.
36. Welters CFM, Dejong CHC, Athanasas G, et al. Effects of parenteral arginine supplementation on the intestinal adaptive response after massive small bowel resection. J Surg Res 1999;85:259-66.
37. Tamada H, Nezu R, Imamura I, et al. The dipeptide alanyl-glutamine prevents intestinal mucosal atrophy in parenterally fed rats. JPEN J Parenter Enteral Nutr 1992;16:110-6.
38. Tamada H, Nezu R, Matsuo Y, et al. Alanyl glutamine-enriched total parenteral nutrition restores intestinal adaptation after either proximal or distal massive resection in rats. JPEN J Parenter Enteral Nutr 1993;17:236-42.
39. Chen K, Nezu R, Sando K, et al. Influence of glutamine-supplemented parenteral nutrition on intestinal amino acid metabolism in rats after small bowel resection. Surg Today 1996;26:618-23.
40. Gardemann A, Watanabe Y, Brobe V, et al. Increase in intestinal glucose absorption and hepatic glucose uptake elicited by luminal but not vascular glutamine in the jointly perfused small intestine and liver of the rat. Biochem J 1992;283:759-65.
41. Rhoads JM, Keku EO, Quinn J, et al. L-glutamine stimulates jejunal sodium and chloride absorption in pig rotavirus enteritis. Gastroenterology 1991;100:683-91.
42. Rhoads JM, Keku EO, Woodard JP, et al. L-glutamine with d-glucose stimulates oxidative metabolism and NaCl absorption in the piglet jejunum. Am J Physiol 1992;263:G960-6.
43. Vanderhoof JA, Blackwood DJ, Mohammadpour H, et al. Effects of oral supplementation of glutamine on small intestinal mucosal mass following resection. J Am Coll Nutr 1992;11:223-7.
44. Michail S, Mohammadpour H, Park JH, et al. Effect of glutamine- supplemented elemental diet on mucosal adaptation following bowel resection in rats. J Pediatr Gastroenterol Nutr 1995;21:394-8.
45. Yang H, Larsson J, Permert J, et al. No effect of bolus glutamine supplementation on the postresectional adaptation of small bowel mucosa in rats receiving chow ad libitum. Dig Surg 2000;17:256-60.
46. Byrne TA, Persinget RL, Young LS, et al. A new treatment for patients with short bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann Surg 1995;222:243-54.
47. Byrne TA, Morrissey TB, Nattakom TV, et al. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr 1995;19:296-302.
48. Wilmore DW, Lacey JM, Soultanakis RP, et al. Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg 1997;226:288-92.
49. Morin CL, Grey VL, Garofalo C. Influence of lipids on intestinal adaptation after resection. In: Robinson JWL, Dowling RH, Riecken EO, editors. Mechanisms in intestinal adaptation. Lancaster (PA): MTP Press; 1982. p. 175-85.
50. Grey VL, Garofalo C, Greenberg GR, et al. The adaptation of the small intestine after resection in response to free fatty acids. Am J Clin Nutr 1984;40:1235-42.
51. Kollman KA, Lien EL, Vanderhoof JA. Dietary lipids influence adaptation after massive small bowel resection. J Pediatr Gastroenterol Nutr 1999;28:41-5.
52. Vanderhoof JA, Park JH, Herrington MK, et al. Effects of dietary menhaden oil on mucosal adaptation after small bowel resection in rats. Gastroenterology 1994;106:94-9.
53. Vanderhoof JA, Grandjean CJ, Kaufmann SS, et al. The effect of high percentage medium-chain triglyceride diet on mucosal adaptation following massive small-bowel resection in rats. JPEN J Parenter Enteral Nutr 1984;8:685-9.
54. Koretz RL, Meyer JL. Elemental diets: facts and fantasies. Gastroenterology 1980;78:393-410.
55. Bines J, Francis D, Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr 1998;26:123-8.
56. McIntyre PB, Fitchew M, Lennard-Jones JE. Patients with a high jejunostomy do not need a special diet. Gastroenterology 1986;91:25-33.
57. Weser E, Babbitt J, Hoban M. Intestinal adaptation. Different growth receptors to disaccharides compared with monosaccharides in rat small bowel. Gastroenterology 1986;91:1521-7.
58. Lai HS, Chen WJ, Chen KM, et al. Effects of monomeric and polymeric diets on small intestine following massive resection. J Formos Med Assoc 1989;88:982-8.
59. Crenn P, Morin M, Joly F, et al. Net digestive absorption and adaptive hyperphagia in adult short bowel patients. Gut 2004;53:1279-86.
60. Williamson R, Bauer F, Ross J, et al. Contributions of bile and pancreatic juice to cell proliferation in ileal mucosa. Surgery 1978;5:570-6.
61. Weser E, Heller R, Tawil T. Stimulation of mucosal growth in rat ileum by bile and pancreatic secretions after jejunal resection. Gastroenterology 1977;73:524-9.
62. Altmann C. Influence of bile and pancreatic secretions on the size of the intestinal villi in the rat. Am J Anat 1971;132:167-78.
63. Morin C, Ling V, Van Caille M. Role of oral intake on intestinal adaptation after massive small-bowel resection in growing rats. Pediatr Res 1978;12:268-71.
64. Ford W, Boelhouwer R, King W, et al. Total parenteral nutrition inhibits intestinal adaptive hyperplasia in young rats: reversal by feeding. Surgery 1984;96:527-34.
65. Buchman A, Moukarzel A, Bhuta S, et al. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. JPEN J Parenter Enteral Nutr 1995;19:453-60.
66. Scolapio J, Fleming C. Nutrition and specific gastrointestinal disease states. Gastroenterol Clin 1998;27:467-79.
67. Johnson L. Regulation of gastrointestinal growth. In: Johnson LR, editor. Physiology of the digestive tract. New York: Raven Press; 1981. p. 169-96.
68. Walsh JH. Role of gastrin as a trophic hormone. Digestion 1990;47:11-6.
69. Ekundayo A, Lee CY, Goodlad RA. Gastrin and the growth of the gastrointestinal tract. Gut 1995;36:203-8.
70. Cortot A, Fleming C, Malagelada J. Improved nutrient absorption after cimetidine in short bowel syndrome with gastric hypersecretion. N Engl J Med 1979;300:79-80.
71. Jeppesen P, Staun M, Tjellesen L, et al. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut 1998;43:763-9.
72. Lobie PE, Breipohl W, Waters MJ. Growth hormone receptor expression in the rat gastrointestinal tract. Endocrinology 1990;126:299-306.
73. Shulman D, Hu C, Duckett G, Lavallee-Grey M. Effects of short-term growth hormone therapy in rats undergoing 75% small intestinal resection. J Pediatr Gastroenterol Nutr 1992;14:3-11.
74. Gomez de Segura IA, Aguilera MJ, Codesal J, et al. Comparative effects of growth hormone in large and small bowel resection in the rat. J Surg Res 1996;62:5-10.
75. Wheeler EE, Challacombe DN. The trophic action of growth hormone, insulin-like growth factor 1, and insulin on human duodenal mucosa cultured in vitro. Gut 1997;40:57-60.
76. Mainoya JR. Effects of bovine growth hormone, human placental lactogen and ovine prolactin on intestinal fluid and ion transport in the rat. Endocrinology 1975;96:1165-70.
77. Mainoya JR. Influence of bovine growth hormone on water and NaCl absorption by the rat proximal jejunum and distal ileum. Comp Biochem Physiol 1982;71:477-9.
78. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology 1997;113:1074-81.
79. Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study. Gut 2000;47:199-205.
80. Ellegaard L, Bosaeus I, Nordgren S, et al. Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg 1997;225:88-96.
81. Seguy D, Vahedi K, Kapel N, et al. Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study. Gastroenterology 2003;124:293-302.
82. Peterson C, Carey H, Hinton P, et al. GH elevates serum IGF-1 levels but does not alter mucosal atrophy in parenterally fed rats. Am J Physiol 1997;272:G1100-8.
83. Le Roith D. Insulin-like growth factors. Mass Med Soc 1997;336:633-9.
84. Lund P. Molecular basis of intestinal adaptation: the role of the insulin-like growth factor system. Ann N Y Acad Sci 1998;859:18-36.
85. Sigalet DL, Martin GR. Hormonal therapy for short bowel syndrome. J Pediatr Surg 2000;35:360-4.
86. Clark R, Carlsson L, Mortensen D. Additive effects on body growth of insulin-like growth factor-I and growth hormone in hypophysectomized rats. Endocrinol Metab 1994;1:49-54.
87. Kupfer S, Underwood L, Baxter R, et al. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor-I by use of both agents simultaneously. J Clin Invest 1996;91:391-6.
88. Lo H, Hinton P, Peterson C, et al. Simultaneous treatment with IGF-I and GH additively increases anabolism in parenterally fed rats. Am J Physiol 1995;269:E368-76.
89. Holst-Pedersen J, Fahrenkrug J. Neurotensin-like immunoreactivities in human plasma: feeding responses and metabolism. Peptides 1986;7:15-20.
90. Baksheev L, Fuller P. Humoral factors in intestinal adaptation. Trends Endocrinol Metab 2000;11:401-5.
91. Wood JG, Hoang HD, Bussjaeger LJ, Solomon TE. Neurotensin stimulates growth of small intestine in rats. Am J Physiol 1988;255:813-7.
92. Evers BM, Izukara M, Towsend CM Jr, et al. Neurotensin prevents intestinal mucosa hypoplasia in rats fed an elemental diet. Dig Dis Sci 1992;37:426-31.
93. De Miguel E, Gomez de Segura I, Bonet H, et al. Trophic effects of neurotensin in massive bowel resection in the rat. Dig Dis Sci 1994;39:59-64.
94. Nightingale JM, Kamm MA, van der Sijp JR, et al. Gastrointestinal hormones in the short bowel syndrome. PYY may be the 'colonic brake' to gastric emptying. Gut 1996;39:267-72.
95. Jeppesen PB, Hartmann B, Hansen BS, et al. Impaired stimulation of glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure. Gut 1999;45:559-63.
96. Gleeson MH, Bloom SR, Polak JM, et al. Endocrine tumor in kidney affecting small bowel structure, motility, and absorptive function. Gut 1971;12:773-82.
97. Hoist JJ, Sorensen TI, Andersen AN, et al. Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. Scand J Gastroenterol 1979;14:205-7.
98. Barry RE, Barisch J, Bray GA, et al. Intestinal adaptation after jejunoileal bypass in man. Am J Clin Nutr 1977;30:32-42.
99. Bloom SR, Polak JM. The hormonal pattern of intestinal adaptation (a major role for enteroglucagon). Scand J Gastroenterol 1982;17:93-103.
100. Taylor RG, Beveridge DJ, Fuller PJ. Expression of ileal glucagons and peptide tyrosine-tyrosine genes. Response to inhibition of polyamine synthesis in the presence of massive small-bowel resection. Biochem J 1992;286:737-41.
101. Roundtree DB, Ulshen MH, Selub S, et al. Nutrient-independent increases in proglucagon and ornithine decarboxylase messenger RNAs after jejunoileal resection. Gastroenterology 1992;103:462-8.
102. Fuller PJ, Beveridge DJ, Taylor RG. Ileal proglucagon gene expression in the rat: characterization in intestinal adaptation using in situ hybridization. Gastroenterology 1993;104:459-66.
103. Ulshen MH, Hoyt EC, Fuller CR, et al. Increased ileal proglucagon expression after jejunectomy is not suppressed by inhibition of bowel growth. Dig Dis Sci 1996;41:677-83.
104. Sarson DL, Scopinaro N, Bloom SR. Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes 1981;5:471-80.
105. Besterman HS, Adrian TE, Malinson CN, et al. Gut hormone release after intestinal resection. Gut 1982;23:854-61.
106. Kennedy HJ, Sarson DJ, Bloom SR, et al. Gut hormone responses in subjects with a permanent ileostomy. Digestion 1982;24:133-6.
107. Gregor M, Stallmach A, Menge H, et al. The role of gut-glucagon-like immunoreactants in the control of gastrointestinal epithelial cell renewal. Digestion 1990;46:59-65.
108. Drucker DJ, Ehrlich P, Asa SL, et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 1996;93:7911-6.
109. Drucker DJ, Deforest L, Brubaker PL. Intestinal response to growth factors administered alone or in combination with h[Gly2]-glucagon-like peptide 2. Am J Physiol 1997;272: G1252-62.
110. Tsai C-H, Hill M, Drucker DJ. Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am J Physiol 1997;272:G662-8.
111. Tsai C-H, Hill M, Asa SL, et al. Intestinal growth-promoting properties of glucagon-like peptide 2 in mice. Am J Physiol 1997;273:E77-84.
112. Ljungmann K, Hartmann B, Kissmeyer-Nielsen P, et al. Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats. Am J Physiol Gastrointest Liver Physiol 2001;281:G779-85.
113. Scott RB, Kirk D, MacNaughton WK, et al. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol 1998;275:G911-21.
114. Munroe D, Gupta A, Kooshesh P, et al. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci U S A 1999;96:1569-73.
115. Wojdemann M, Wettergren A, Hartmann B, et al. Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide 2. J Clin Endocrinol Metab 1999;84:2513-7.
116. Jeppesen PB, Hartmann B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 2001;120:806-15.
117. Brubaker PL, Izzo A, Hill M, et al. Intestinal function in mice with small bowel growth induced by glucagon-like peptide 2. Am J Physiol 1997;272:E1050-8.
118. Kato Y, Yu D, Schwartz MZ. Glucagon-like peptide 2 enhances small intestinal absorptive function and mucosal mass in vivo. J Pediatr Surg 1999;34:18-20.
119. Wojdemann M, Wettergren A, Hartmann B, et al. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand J Gastroenterol 1998;33:828-32.
120. Jeppesen PB, Hartmann B, Thulesen J, et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut 2000;47:370-6.
121. Litvak D, Hellmich M, Evers B, et al. Glucagon-like peptide-2 is a potent growth factor for small intestine and colon. J Gastrointest Surg 1998;2:146-50.
122. Jeppesen PB. Clinical significance of GLP-2 in short-bowel syndrome. J Nutr 2003;133:3771-4.
123. Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem 1979;48:193-216.
124. Marti U, Burwen S, Jones A. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update. Hepatology 1989;9:126-38.
125. Nightingale J, editor. Intestinal failure. London: Greenwich Medical Media Limited; 2001.
126. Taylor RG, Verity K, Fuller PJ. Heal glucagons gene expression: ontogeny and response to massive small bowel resection. Gastroenterology 1990;99:724-9.
127. Tsujikawa T, Bamba T, Hosada S. The trophic effect of epidermal growth factor on morphologic changes and polyamine metabolism in the small intestine of rats. Gastroenterol Jpn 1990;25:328-34.
128. Swaniker F, Guo W, Fonkalsrud E, Diamond J. The effect of epidermal growth factor on mucosal function after ileal resection. J Surg Res 1995;58:565-9.
129. O'Loughlin E, Winter M, Shun A, et al. Structural and functional adaptation following jejunal resection in rabbits: effect of epidermal growth factor. Gastroenterology 1994;107:87-93.
130. Barnard J, Beauchamp R, Russell W, et al. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 1995;108:564-80.
131. Goodlad RA, Savage AP, Lenton W, et al. Does resection enhance the response of the intestine to urogastrone-epidermal growth factor in the rat? Clin Sci (Lond) 1988;75:121-6.
132. Flaut AG. Trefoil peptides in the defense of the gastrointestinal tract. N Engl J Med 1997;336:506-7.
133. Sands BE, Podolsky DK. The trefoil peptide family. Annu Rev Physiol 1996;58:253-73.
134. Playford RJ, Marchbank T, Chinery R, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995;108:108-16.
135. Dignass A, Lynch-Devaney K, Kindon H, et al. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 1994;94:376-83.
136. Farrell J, Taupin D, Koh T, et al. TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest 2002;109:193-204.
137. Murphy MS. Growth factors and the gastrointestinal tract. Nutrition 1998;14:771-4.
138. Kato Y, Yu D, Schwartz MZ. Enhancement of intestinal adaptation by hepatocyte growth factor. J Pediatr Surg 1998;33:235-9.
139. Johnson W, DiPalma C, Ziegler T, et al. Keratinocyte growth factor enhances early gut adaptation in a rat model of short bowel syndrome. Vet Surg 2000;29:17-27.
140. Liu Q, Du XX, Schindel DT, et al. Trophic effects of interleukin-11 in rats with experimental short bowel syndrome. J Pediatr Surg 1996;31:1047-50.
141. Fiore NF, Ledniczky G, Liu Q, et al. Comparison of interleukin-11 and epidermal growth factor on residual small intestine after massive small bowel resection. J Pediatr Surg 1998;33:24-9.
142. Kiessling S, Muller-Newen G, Leeb S, et al. Functional expression of the interleukin-11 receptor a-chain and evidence of antiapoptotic effects in human colonic epithelial cells. J Biol Chem 2004;279:10304-15.
143. Alavi K, Prasad R, Lundgren K, Schwartz MZ. Interleukin-11 enhances small intestine absorptive function and mucosal mass after intestinal adaptation. J Pediatr Surg 2000;35:371-4.